Avadel Pharmaceuticals plc AVDL
21.64 USD 0.00 (+0.00%)
Feb 13, 2026, 9:30 AM EST
21.64 Day range 21.64
52-week range unavailable
- YTD
- +0.42%
- 1 year
- +140.71%
Analyst view
Consensus: hold
Hold
Price target (mean) 20.71 -4.3% downside
Now 21.64
- Target (low)
- 18.50
- Target (mean)
- 20.71
- Target (high)
- 23.00
Ratings (0m) 9 0 buy · 9 hold · 0 sell
- Strong buy0
- Buy0
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 10
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.14429 | -0.15 – 0.73 | -0.05 | +388.6% | 79.66M | +58.0% | 7 |
| Next quarter | 0.13 | 0.08 – 0.17 | -0.05 | +360.0% | 80.07M | +52.5% | 5 |
| Current year | 0.20857 | -0.10 – 0.79 | -0.51 | +140.9% | 277.42M | +64.0% | 7 |
| Next year | 0.78 | 0.59 – 1.14 | 0.20857 | +274.0% | 360.28M | +29.9% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 7, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 28, 2025 | UBS | Downgrade | Buy | Neutral |
| Oct 23, 2025 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Oct 23, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Oct 22, 2025 | Jefferies | Downgrade | Buy | Hold |
| Oct 22, 2025 | Needham | Downgrade | Buy | Hold |
| Sep 5, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 3, 2025 | Wells Fargo | Initiated | — | Equal-Weight |
| Aug 21, 2025 | UBS | Maintained | Buy | Buy |
| Aug 8, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 8, 2025 | Needham | Reiterated | Buy | Buy |
| Apr 9, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 4, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 4, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 3, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 11, 2025 | Deutsche Bank | Initiated | — | Buy |
| Jan 13, 2025 | UBS | Maintained | Buy | Buy |
| Jan 10, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 9, 2025 | Needham | Maintained | Buy | Buy |
| Nov 12, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 31, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 9, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 5, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Mar 5, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 5, 2024 | Piper Sandler | Maintained | Overweight | Overweight |